Neonatal testosterone exposure protects adult male rats from stroke

Neuroendocrinology

Volumn 97, Issue 3, 2013, Pages 271-282

  Persky, Rebecca W ^a   Liu, Fudong ^a   Xu, Yan ^a   Weston, Gillian ^a   Levy, Stephanie ^a   Roselli, Charles E ^b   McCullough, Louise D ^a  

^a UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Aromatase; Estradiol; Ischemic injury; Sex dimorphism; Testosterone

Indexed keywords

ANDROSTANOLONE; AROMATASE; ESTRADIOL; TESTOSTERONE PROPIONATE; X LINKED INHIBITOR OF APOPTOSIS; SESAME SEED OIL; TESTICULAR AROMATASE; TESTOSTERONE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BRAIN INFARCTION SIZE; BRAIN TISSUE; CELL DEATH; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; ESTRADIOL BLOOD LEVEL; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; NEUROPROTECTION; NONHUMAN; PERINATAL DRUG EXPOSURE; PRIORITY JOURNAL; RAT; SEX DIFFERENCE; SHAM PROCEDURE; TREATMENT DURATION; ADULT; ADULTHOOD; BODY WEIGHT; GONAD; NEUROLOGICAL DEFICIT SCORE; NEWBORN; SCORING SYSTEM; TESTOSTERONE BLOOD LEVEL;

ANIMALS; ANIMALS, NEWBORN; AROMATASE; BRAIN INFARCTION; DIHYDROTESTOSTERONE; ESTRADIOL; INFARCTION, MIDDLE CEREBRAL ARTERY; MALE; RATS; STROKE; TESTIS; TESTOSTERONE PROPIONATE; X-LINKED INHIBITOR OF APOPTOSIS PROTEIN;

EID: 84877923441     PISSN: 00283835     EISSN: 14230194     Source Type: Journal    
DOI: 10.1159/000343804     Document Type: Article

References (51)

1. Roger VL, Go AS, Lloyd-Jones DM, et al: Heart disease and stroke statistics-2011 update: a report from the American Heart Association. Circulation 2011; 123:e18-e209.
2. Appelros P, Stegmayr B, Terent A: Sex differences in stroke epidemiology: a systematic review. Stroke 2009; 40:1082-1090.
3. Persky RW, Turtzo LC, McCullough LD: Stroke in women: disparities and outcomes. Curr Cardiol Rep 2010; 12: 6-13.
4. Normann S, de Veber G, Fobker M, et al: Role of endogenous testosterone concentration in pediatric stroke. Ann Neurol 2009; 66: 754-758.
5. Vannucci SJ, Hurn PD: Gender differences in pediatric stroke: is elevated testosterone a risk factor for boys? Ann Neurol 2009; 66: 713-714.
6. Liu F, Yuan R, Benashski SE, McCullough LD: Changes in experimental stroke outcome across the life span. J Cereb Blood Flow Metab 2009; 29: 792-802.
7. Du L, Bayir H, Lai Y, et al: Innate gender-based proclivity in response to cytotoxicity and programmed cell death pathway. J Biol Chem 2004; 279: 38563-38570.
8. Kawamata T, Alexis NE, Dietrich WD, Finklestein SP: Intracisternal basic fibro-blast growth factor (bFGF) enhances behavioral recovery following focal cerebral infarction in the rat. J Cereb Blood Flow Metab 1996; 16:542-547.
9. Liu M, Dziennis S, Hurn PD, Alkayed NJ: Mechanisms of gender-linked ischemic brain injury. Restor Neurol Neurosci 2009; 27: 163-179.
10. Cheng J, Alkayed NJ, Hurn PD: Deleterious effects of dihydrotestosterone on cerebral ischemic injury. J Cereb Blood Flow Metab 2007; 27:1553-1562.
11. Uchida M, Palmateer JM, Herson PS, De-Vries AC, Cheng J, Hurn PD: Dose-dependent effects of androgens on outcome after focal cerebral ischemia in adult male mice. J Cereb Blood Flow Metab 2009; 29:1454-1462.
12. Yeap BB, Hyde Z, Almeida OP, et al: Lower testosterone levels predict incident stroke and transient ischemic attack in older men. J Clin Endocrinol Metab 2009; 94: 2353-2359.
13. Hollander M, Koudstaal PJ, Bots ML, Grobbee DE, Hofman A, Breteler MM: Incidence, risk, and case fatality of first ever stroke in the elderly population. The Rotterdam Study. J Neurol Neurosurg Psychiatry 2003; 74: 317-321.
14. Roselli CE, Ellinwood WE, Resko JA: Regulation of brain aromatase activity in rats. Endocrinology 1984; 114: 192-200.
15. Roselli CE, Liu M, Hurn PD: Brain aromati-zation: classic roles and new perspectives. Semin Reprod Med 2009; 27:207-217.
16. Lephart ED: A review of brain aromatase cy-tochrome P450. Brain Res Brain Res Rev 1996; 22: 1-26.
17. Bardet SM, Cornil CA, Balthazart J: Testosterone recruits new aromatase-imunoreac-tive cells in neonatal quail brain. Neurore-port 2010; 21: 376-380.
18. Carswell HV, Dominiczak AF, Garcia-Segura LM, Harada N, Hutchison JB, Macrae IM: Brain aromatase expression after experimental stroke: topography and time course. J Steroid Biochem Mol Biol 2005; 96:89-91.
19. Lang JT, McCullough LD: Pathways to isch-emic neuronal cell death: are sex differences relevant? J Transl Med 2008; 6:33.
20. Grabowski M, Brundin P, Johansson BB: Paw-reaching, sensorimotor, and rotational behavior after brain infarction in rats. Stroke 1993; 24:889-895.
21. Bourguiba S, Genissel C, Lambard S, Bourai-ma H, Carreau S: Regulation of aromatase gene expression in Leyd ig cells and germ cells. J Steroid Biochem Mol Biol 2003; 86:335-343.
22. Rosen GD, Herman AE, Galaburda AM: Sex differences in the effects of early neocortical injury on neuronal size distribution of the medial geniculate nucleus in the rat are mediated by perinatal gonadal steroids. Cereb Cortex 1999; 9: 27-34.
23. McCullough LD, Zeng Z, Blizzard KK, Deb-choudhury I, Hurn PD: Ischemic nitric oxide and poly (ADP-ribose) polymerase-1 in cerebral ischemia: male toxicity, female protection. J Cereb Blood Flow Metab 2005; 25: 502-512.
24. Thulin T, Fagher B, Grabowski M, Ryding E, Elmqvist D, Johansson BB: Cerebral blood flow in patients with severe hypertension, and acute and chronic effects of felodipine. J Hypertens 1993; 11: 83-88.
25. Li X, Blizzard KK, Zeng Z, DeVries AC, Hurn PD, McCullough LD: Chronic behavioral testing after focal ischemia in the mouse: functional recovery and the effects of gender. Exp Neurol 2004; 187:94-104.
26. Liu F, Li Z, Li J, Siegel C, Yuan R, McCullough LD: Sex differences in caspase activation after stroke. Stroke 2009; 40:1842-1848.
27. McCullough LD, Hurn PD: Estrogen and ischemic neuroprotection: an integrated view. Trends Endocrinol Metab 2003; 14: 228-235.
28. Walczak-Jedrzejowska R, Slowikowska-Hilczer J, Marchlewska K, Oszukowska E, Kula K: Administration of testosterone inhibits initiation of seminal tubule growth and decreases Sertoli cell number in the earliest period of rat's postnatal development. Folia Histochem Cytobiol 2009; 47:S149-S154.
29. Alexis NE, Back T, Zhao W, Dietrich WD, Watson BD, Ginsberg MD: Neurobehavioral consequences of induced spreading depression following photothrombotic middle cerebral artery occlusion. Brain Res 1996; 706: 273-282.
30. Liu F, Benashski SE, Persky R, Xu Y, Li J, Mc-Cullough LD: Age-related changes in AMP-activated protein kinase after stroke. Age (Dordr) 2012; 34: 157-168.
31. de Vries GJ, Sodersten P: Sex differences in the brain: the relation between structure and function. Horm Behav 2009; 55: 589-596.
32. Carter MQ, Xue K, Brandl MT, et al: Functional metagenomics of Escherichia coli O157:H7 interactions with spinach indigenous microorganisms during biofilm formation. PLoS One 2012; 7:e44186.
33. Nardo L, Alizai H, Virayavanich W, et al: Lumbosacral transitional vertebrae: association with low back pain. Radiology 2012, Epub ahead of print.
34. Ishii H, Sato S, Yin C, Sakuma Y, Kato M: Cetrorelix, a gonadotropin-releasing hormone antagonist, induces the expression of melatonin receptor 1a in the gonadotropin-releasing hormone neuronal cell line GT1-7. Neuroendocrinology 2009; 90:251-259.
35. Liu FL, Sheng QS, Chen WB, Wang JH, Hua HJ, Lin JJ: Hand-assisted laparoscopic surgery in radical resection of rectal cancer (in Chinese). Zhonghua Wai Ke Za Zhi 2012; 50: 622-624.
36. Jiang ZW, Zhao K, Wang G, et al: Application of surgical robotic system in patients with gastric cancer: a report of 120 cases (in Chinese). Zhonghua Wei Chang Wai Ke Za Zhi 2012; 15:801-803.
37. Cheng J, Hurn PD: Sex shapes experimental ischemic brain injur y. Steroids 2010; 75: 754-759.
38. Basaria S, Coviello AD, Travison TG, et al: Adverse events associated with testosterone administration. N Engl J Med 2010; 363:109-122.
39. Yuan F, Song L, Liu F, Gu L, Zhang Y: Eu-karyotic DNA mismatch repair in vitro. Methods Mol Biol 2012; 920:149-162.
40. Dash RJ, Sethi BK, Nalini K, Singh S: Circulating testosterone in pure motor stroke. Funct Neurol 1991; 6:29-34.
41. Manwani B, McCullough LD: Sexual dimorphism in ischemic stroke: lessons from the laboratory. Womens Health (Lond Engl) 2011; 7:319-339.
42. Liu F, Benashski SE, Xu Y, Siegel M, Mc-Cullough LD: Effects of chronic and acute oestrogen replacement therapy in aged animals after experimental stroke. J Neuroen-docrinol 2012; 24:319-330.
43. McCullough LD, Blizzard K, Simpson ER, Oz OK, Hurn PD: Aromatase cytochrome P450 and extra gonadalestrogen play a role in ischemic neuroprotection. J Neurosci 2003; 23: 8701-8705.
44. Lavaque E, Mayen A, Azcoitia I, Tena-Sempere M, Garcia-Segura LM: Sex differences, developmental changes, response to injury and cAMP regulation of the mRNA levels of steroidogenic acute regulatory protein, cyto-chrome p450scc, and aromatase in the olivo-cerebellar system. J Neurobiol 2006; 66:308-318.
45. Konkle AT, McCarthy MM: Developmental time course of estradiol, testosterone, and dihydrotestosterone levels in discrete regions of male and female rat brain. Endocrinology 2011; 152: 223-235.
46. Duskova M, Pospisilova H: The role of non-aromatizable testosterone metabolite in metabolic pathways. Physiol Res 2011; 60: 253-261.
47. Fennell MJ, Scanes CG: Inhibition of growth in chickens by testosterone, 5 alpha-dihy-drotestosterone, and 19-nortestosterone. Poult Sci 1992; 71: 357-366.
48. Renolleau S, Fau S, Goyenvalle C, et al: Specific caspase inhibitor Q-VD-OPh prevents neonatal stroke in P7 rat: a role for gender. J Neurochem 2007; 100:1062-1071.
49. Renolleau S, Fau S, Goyenvalle C, Charriaut-Marlangue C: Sex, neuroprotection, and neonatal ischemia. Dev Med Child Neurol 2007; 49: 477, author reply 477-478.
50. Siegel C, Li J, Liu F, Benashski SE, Mc-Cullough LD: miR-23a regulation of X-linked inhibitor of apoptosis (XIAP) contributes to sex differences in the response to cerebral ischemia. Proc Natl Acad Sci USA 2011; 108:11662-11667.
51. Mendonca DF, Chammas R, Liu FT, et al: The inactive form of glycogen synthase ki-nase-3beta is associated with the development of carcinomas in galectin-3 wild-type mice, but not in galectin-3-deficient mice. Int J Clin Exp Pathol 2012; 5:547-554.